- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01137617
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients. (SCS)
The purpose of this study is to better understand how the Spinal Cord Stimulator works in relieving chronic pain.
The investigators are asking subject to take part in this study because who are chronic pain patients who already have a Spinal Cord Stimulator (SCS) in place.
The investigators hypothesize that chronic pain patients will have higher heat pain threshold and heat pain tolerance over the painful areas with the SCS on.
QST (Quantitative Sensory Testing, a heat/cold simulation test) might be an objective helpful tool for prudent patient selection for an expensive and invasive procedure for future SCS placement.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Sixty subjects who already have an implanted SCS device for pain management at the MGH Center for Pain Medicine and other Partners affiliated pain centers will be enrolled.
Inclusion Criteria:
- Subject is 18 years or older.
- Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.
Exclusion Criteria:
- Subject has neurological disease or a condition causing sensory deficit to the painful area.
- Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.
- Subjects who are unable to travel to the study center.
It will be a one time outpatient visit study, which will include the following:
Brief pain history and Neurological examination
- Medical History (including medication use);
- Pain location, intensity, character and if known, etiology, duration;
- Maps of pain locations and paresthesia locations;
- Sensory neurological examination (e.g., alcohol swab, cotton swab, pinprick and vibration);
- A check on routine vital signs (blood pressure, pulse, pulse oximetry).
QST will include the following:
- Warm sensation, heat pain threshold, heat pain tolerance and wind-up. A cut-off of 53°C for heat will be preset to avoid tissue damage.
- QST will be done on two areas; painful area and non-painful area without paresthesia with the SCS turned off.
- Subject will then turn on SCS and a repeat QST will be performed on the painful and non-painful areas.
- QST tests will be performed in a quiet room at temperature 25º 2° C. The time and duration of the QST tests will be recorded.
QST will be performed at least 4 hours and no later than 6 hours after the last dose of long acting opioid and after last SCS on time. In this way the investigators will try to avoid recording possible end dose withdrawal and provide sufficient time for the subject to return to baseline for their SCS therapy.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02114
- MGH Center for Translational Pain Research
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Subject is 18 years or older.
- Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.
Exclusion Criteria:
- Subject has neurological disease or a condition causing sensory deficit to the painful area.
- Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.
- Subjects who are unable to travel to the study center.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Bare etui
- Tidsperspektiver: Tverrsnitt
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Warm Sensation (WS) Threshold- Pain Site
Tidsramme: WS threshold is assessed once at Visit 1
|
WS threshold is a type of Quantitative Sensory Test (QST).
A contact thermode was attached to the subject's painful area that has SCS coverage.
The thermode increased by 1°C/sec from a baseline of 32°C.
Subjects were instructed to stop stimulation when they first perceived a warm sensation.
Subjects performed this test with their SCS off and again with their SCS on.
|
WS threshold is assessed once at Visit 1
|
Heat Pain (HP) Threshold- Pain Site
Tidsramme: HP threshold is assessed once at Visit 1
|
Heat Pain threshold is a type of QST.
A contact thermode was attached to the subject's painful area that has SCS coverage.
The thermode increased by 1°C/sec from a baseline of 32°C.
Subjects were instructed to stop the stimulation when pain was first detected.
Subjects performed this test with their SCS off and again with their SCS on.
|
HP threshold is assessed once at Visit 1
|
Heat Pain Tolerance- Pain Site
Tidsramme: Heat Pain Tolerance is assessed once at Visit 1
|
Heat Pain threshold is a type of QST.
A contact thermode was attached to the subject's painful area that has SCS coverage.
The thermode increased by 1°C/sec from a baseline of 32°C.
Subjects were instructed to stop the stimulation when pain was no longer tolerable.
Subjects performed this test with their SCS off and again with their SCS on.
|
Heat Pain Tolerance is assessed once at Visit 1
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Shihab Ahmed, MD, Massachusetts General Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2010P 000425
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kronisk smerte
-
Clínica de Oftalmología de Cali S.AFullførtMeibomian kjerteldysfunksjon | Eyes Dry ChronicColombia
-
Alcon ResearchFullført
-
Jules Bordet InstituteMacopharma; Belgian Hematological SocietyRekrutteringRefractory Chronic Graft Versus Host Disease (cGVHD)Belgia
-
East Carolina UniversityTilbaketrukket
-
Wake Forest University Health SciencesRekruttering
-
Cairo UniversityFullførtCervical Myofascial Pain SyndromeEgypt
-
Dilşad SindelFullførtKvinnelige pasienter med Myofascial Pain Syndrome (MPS) relatert til øvre Trapezius Active Trigger Points (TP)
-
Brugmann University HospitalTilbaketrukketPhantom Limb Pain (PLP) | Primær/sekundær arrhyperalgesiBelgia
-
Oslo University HospitalUniversity of Oslo; Fysiofondet; Oslo Metropolitan UniversityRekrutteringGluteal tendinopati | Trochanterisk bursitt | Lateral hoftesmerter | GTPS - Greater Trochanteric Pain SyndromeNorge
-
Occyo GmbHUniversity Clinic for Ophthalmology and Optometry- SalzburgFullførtLimbal stamcelle mangel | Hornhinnesykdom | Eyes Dry Chronic | Kronisk konjunktivitt i begge øyne | Øyelesjon | Øyesykdom; Grå stær | Øyne Tørr følelse av | Hornhinne betent | Hornhinne; Skade, slitasje | HornhinneinfeksjonØsterrike